GNH Community

nonprofits,local leaders & Grt.New Haven business sharing information

ACA Provides Public Access to Key Health Industry Information

Under Obamacare (ACA), the Public Now Has Access to Important Medical Industry Data.   

How much is the health industry paying your doctor?  Why is this important?

What prescriptions do you get? Do some doctors have a financial interest in what is prescribed for you? This article will help you to understand why some with deep pockets so oppose the ACA.  Yes, the ACA might be getting between you and your doctor, but not in the manner being propagandize in some commercials. Civic Engagement – Powerful!

Click to read this:  http://projects.ctmirror.org/doc_payments/

This is really important information for us the consumers of health care.  Do you know that there are groups that try to prevent generic versions of drug from being sold so that manufacturers of the more costly version can make millions of dollars in profits?  Whose needs are being served when doctors insist that patients purchase the more expensive version of a drug when the identical generic version is available at one-third the cost? Are some doctors being paid to represent pharmaceuticals when they see patients?

Of course, not all generics are identical in total composition to the original, but what are the important differences and do those differences affect the outcomes of treatment? To answer those and other relevant questions we refer you to experts in the topic:

What are generic drugs?

A generic drug is a chemically equivalent, lower-cost version of a brand-name drug, costing 30-80% less! A brand-name drug and its generic version must have the same active ingredient, dosage, safety, strength, usage directions, quality, performance and intended use.

Are generic drugs as safe as brand-name drugs?

Yes. Generic and brand-name drugs must meet the exact same standards for effectiveness, safety and quality. 

Generic vs Brand Drugs - HealthSmart http://www.healthsmart.com/WellnessResourceCenter/GenericVsBrandDru...

The article below contains important information for health care consumers. It behooves us, the consumers, to be health smart in how we consume and what we consume.

Here is another resource regarding Generics versus Brand Name: Worst Pill - Best Pill

Myths and Facts About Generic Drugs

Unless you want to waste a large amount of money—often hundreds of dollars a year—by using brand-name instead of generic drugs, you should ask for the generic version, especially if you are starting on a drug for the first time. (See table below.) One of the few bits of comparative information about prescription drugs readily accessible to consumers is the retail price of brand-name versus generic drugs. You can get this information easily by asking your pharmacist. The table below was prepared by simply phoning a local pharmacy. http://www.worstpills.org/public/page.cfm?  

Public gets first look at health industry payments to doctors: Ana Radelat | Oct. 22, 2014

WashingtonPharmaceutical companies and medical-device manufacturers paid more than $6 million to about 5,400 Connecticut doctors for various services during the last five months of 2013, a Connecticut Mirror examination of a newly released federal database shows.

The information was collected under a provision of the Affordable Care Act that is designed to help consumers understand the financial relationships between the health care industry and the nation’s physicians. Though only a five-month snapshot, the new data provides the public with the ability to  search actual payments to their own doctors for the first time.

Called "Open Payments," the recent release -- by the Centers for Medicare & Medicaid Services (CMS), a Department of Health and Human Services agency -- details $3.5 billion in payments to doctors nationwide for consulting fees, travel reimbursements, and other items between Aug. 1 and Dec. 31 of 2013. The federal government plans more complete, annual disclosures in the future.

Dr. Shantanu Agrawal, deputy administrator and director of the Center for Program Integrity at CMS, said, “Open Payments does not identify which financial relationships are beneficial and which could cause conflicts of interest. It simply makes the data available to the public.”

http://ctmirror.org/public-gets-first-look-at-health-industry-payme...

OneWorld Progressive Institute, Inc., is a small group of committed volunteers who produce community information and education programs on health literacy, education and civic engagement.  We also find good information and post informative blogs about issues we believe shine light. Learn more about us at our web site: www.oneworldpi.org/   and visit http://www.oneworldpi.org/health/index.html

https://www.youtube.com/user/oneworldpi/videos   - OneWorld’s YouTube – Please Visit https://www.facebook.com/pages/OneWorld-Progressive-Institute-Inc/151551484879941

Views: 15

Comment

You need to be a member of GNH Community to add comments!

Join GNH Community

Welcome (Bienvenido, Benvenuto, Powitanie, Bonjour! Willkomme,歡迎, ברוךהבא أهلا وسهلا, Bonvenon) to GNH Community. Traducción de esta página

Imagine. Inform. Invest. Inspire.

Working together to build a stronger community - now and forever

 

 

Open Street Project

An Open Streets Family Reunion: Reflections from the 2018 Open Streets Summit

By Ryan O’Connor, Director of Programs, 8 80 Cities Recently 8 80 Cities wrote a blog post about open streets being a labour of love. That being the case, the 2018 Open Streets Summit in New Orleans felt like a family reunion of sorts. It was rejuvenating to see old and new friends who share our passion for open streets and are working tirelessly to create healthier, happier, and more connected communities across the world. The event, which took place on September 15-16, brought together more than 50 leaders who currently organize open streets programs or are interested in bringing the...

The post An Open Streets Family Reunion: Reflections from the 2018 Open Streets Summit appeared first on Open Streets Project.

Open Streets Summit Draft Agenda

We hope you are getting ready and feel excited about the Open Streets Summit in Gretna/New Orleans! Taking place from September 15-16, 2018, the Summit will feature tours, presentations and networking opportunities with open streets champions and organizers from across the continent. Attendees will learn about the nuts and bolts of starting or scaling up open streets programs, including: Route design and planning Partnerships with business and officials Social inclusion Safety and logistics Marketing and promotion Program evaluation through measurable goals and metrics If you haven’t done it yet, click here to register for the Open Streets Summit only or...

The post Open Streets Summit Draft Agenda appeared first on Open Streets Project.

Open Streets Summit Speakers Announced!

The Open Streets Project is proud to announce that Ed Solis from Viva Calle (San Jose, CA), Romel Pascual from CicLAvia (Los Angeles, CA), Jaymie Santiago and Charles Brown from New Brunswick Ciclovia will join us as speakers for the 2018 Open Streets Summit in New Orleans and Gretna! Taking place from September 15-16 2018, the Summit will feature: Behind the scenes tour of the City of Gretna’s inaugural open streets program. Workshops, presentations, and networking opportunities with open streets champions and organizers from across the continent. Training and inspiration for both -novice and experienced- open streets organizers and supporters...

The post Open Streets Summit Speakers Announced! appeared first on Open Streets Project.

Local Initiatives Support Corporation

The Rise of San Diego’s Little Saigon

As we commemorate Asian American and Pacific Islander Heritage Month at LISC, we are turning the spotlight on San Diego’s Little Saigon, a Vietnamese American cultural and business district that is forging resiliency, visibility and an inclusive future within the city’s ethnically diverse City Heights neighborhood. (Images courtesy AjA Project and Little Saigon Stories)

LISC CEO Talks Transportation Access on Global Citizen's “Vax Because”

As part of their worldwide vaccine access campaign, Vax Because, Global Citizen invited LISC CEO Lisa Glover and Uber's global head of social impact Julia Paige to discuss their $11 million Vaccine Access Fund, designed to upend barriers to transportation to vaccination sites—barriers that primarily affect undeserved communities of color. Said Glover in the video interview, together with Uber, “we can deliver the resources to our partners that are trusted on the ground, and they can work with their communities to get the transportation needs met.”

© 2021   Created by Lee Cruz.   Powered by

Badges  |  Report an Issue  |  Terms of Service